Viewing nowKwangdong Atorvastatin Tablets 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

MFDS item code 201203609 · Approved 2012.04.30 · Insurance code 641805210
Improvement of hyperlipidemia and familial hypercholesterolemia in children; prevention of cardiovascular diseases
This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction, stroke, the need for vascular surgery, and angina in adults with risk factors for coronary heart disease and in patients with type 2 diabetes mellitus. Additionally, it has been shown to reduce the risk of myocardial infarction, stroke, angina, and hospitalization due to congestive heart failure in patients who already have clinical evidence of coronary heart disease. This drug is also effective in treating hyperlipidemia, reducing total cholesterol and LDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing HDL cholesterol. It is used as an adjunct to dietary therapy in patients with high serum triglycerides. Moreover, it is used in conjunction with diet to lower cholesterol levels in pediatric patients aged 10 to 17 years who have familial hypercholesterolemia. Overall, it is used for the improvement of cardiovascular diseases and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when an LDL cholesterol reduction of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or after dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or alone when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in older patients aged 70 years or older are generally similar to those in adult patients.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related side effects. If muscle pain or weakness worsens or if creatine kinase levels increase significantly, discontinue use immediately and consult a healthcare professional. This medication should not be used in patients with certain liver diseases or severely impaired liver function, in pregnant or potentially pregnant women, in breastfeeding women, in children under 10 years of age, and in patients taking certain other medications. Patients with a history of alcohol abuse or liver disease, impaired kidney function, hypothyroidism, and elderly patients should exercise caution while using this medication, and liver and muscle conditions should be monitored through regular check-ups. Although side effects of this medication are generally mild and transient, various symptoms such as indigestion, headaches, muscle pain, fatigue, and allergic reactions may occur, and persistent unusual symptoms should be reported to a healthcare professional. Particularly, since this medication may affect liver function, if symptoms of hepatitis or jaundice occur, discontinue use immediately and seek medical attention. This medication may interact with other drugs, so patients must inform their healthcare providers of any current medications, especially when taking certain antibiotics, antifungals, some antiviral medications, or grapefruit juice. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should practice appropriate contraception during treatment. The long-term safety and efficacy of this medication in children and adolescents have not been sufficiently studied; thus, caution is advised in patients under 18 years of age. In cases of overdose, there are no specific antidotes, so appropriate treatment should be administered based on symptoms, and liver function and muscle enzyme levels should be monitored regularly. This medication should be stored out of reach of children and in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is best to keep it at room temperature between 1°C and 30°C to maintain its effectiveness.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.